Docusign (NASDAQ:DOCU) Given “Buy” Rating at BTIG Research

BTIG Research restated their buy rating on shares of Docusign (NASDAQ:DOCUFree Report) in a research report report published on Wednesday,Benzinga reports. BTIG Research currently has a $70.00 price target on the stock.

A number of other equities analysts have also commented on DOCU. UBS Group lowered their price target on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. Piper Sandler cut their price objective on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Weiss Ratings restated a “hold (c)” rating on shares of Docusign in a research report on Wednesday, January 21st. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a report on Tuesday, March 10th. Finally, Bank of America dropped their price target on shares of Docusign from $102.00 to $82.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Five equities research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $66.67.

Get Our Latest Research Report on Docusign

Docusign Trading Up 2.9%

NASDAQ:DOCU opened at $48.90 on Wednesday. The stock has a 50 day simple moving average of $50.69 and a 200 day simple moving average of $64.35. The stock has a market cap of $9.79 billion, a P/E ratio of 33.04, a PEG ratio of 2.07 and a beta of 1.03. Docusign has a 1-year low of $40.16 and a 1-year high of $94.67.

Docusign (NASDAQ:DOCUGet Free Report) last issued its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 EPS for the quarter, beating analysts’ consensus estimates of $0.95 by $0.06. Docusign had a return on equity of 16.70% and a net margin of 9.60%.The firm had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. During the same period in the prior year, the firm posted $0.86 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. As a group, sell-side analysts forecast that Docusign will post 1.17 EPS for the current year.

Docusign announced that its board has authorized a stock buyback program on Tuesday, March 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to buy up to 21% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

Insider Activity

In other Docusign news, CFO Blake Jeffrey Grayson sold 6,500 shares of the stock in a transaction dated Friday, January 9th. The shares were sold at an average price of $70.00, for a total transaction of $455,000.00. Following the sale, the chief financial officer directly owned 111,713 shares in the company, valued at $7,819,910. This represents a 5.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.05, for a total transaction of $402,300.00. Following the completion of the transaction, the executive directly owned 68,970 shares in the company, valued at approximately $4,624,438.50. This represents a 8.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 51,477 shares of company stock valued at $3,521,607. Corporate insiders own 1.01% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in DOCU. NewEdge Advisors LLC raised its position in Docusign by 36.4% during the first quarter. NewEdge Advisors LLC now owns 9,202 shares of the company’s stock valued at $749,000 after purchasing an additional 2,457 shares in the last quarter. Police & Firemen s Retirement System of New Jersey boosted its holdings in shares of Docusign by 4.0% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 30,626 shares of the company’s stock valued at $2,385,000 after purchasing an additional 1,176 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of Docusign by 7.7% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 52,029 shares of the company’s stock valued at $4,053,000 after purchasing an additional 3,737 shares during the last quarter. SG Americas Securities LLC increased its stake in shares of Docusign by 153.4% in the 2nd quarter. SG Americas Securities LLC now owns 16,344 shares of the company’s stock valued at $1,273,000 after purchasing an additional 9,893 shares during the last quarter. Finally, Cetera Investment Advisers raised its holdings in shares of Docusign by 7.3% during the 2nd quarter. Cetera Investment Advisers now owns 51,606 shares of the company’s stock worth $4,020,000 after buying an additional 3,507 shares in the last quarter. 77.64% of the stock is owned by institutional investors.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Q4 results and FY27 outlook beat estimates — DocuSign reported adjusted EPS of $1.01 and revenue of $836.9M, topping Street forecasts and signaling continued subscription growth and momentum into fiscal 2027. Docusign’s Q4 Earnings and Revenues Surpass Estimates, Increase Y/Y
  • Positive Sentiment: Share‑repurchase boost — Management authorized a $2.0 billion increase to the buyback program, a direct capital‑return action that supports EPS and signals confidence from the board. PR Newswire: Share Repurchase Increase
  • Positive Sentiment: Product traction in IAM and AI — Management highlighted strong IAM ARR (> $350M after 18 months) and plans to grow IAM share and AI partnerships, supporting secular expansion beyond e‑signatures. Seeking Alpha: IAM ARR and AI Partnerships
  • Neutral Sentiment: Analysts and investors want higher top‑line acceleration — Coverage notes that while results showed traction, many want to see sustained >10% revenue growth before committing, leaving some investors on the sidelines. MSN: Analysts Wait for 10%+ Revenue Growth
  • Neutral Sentiment: Some buy ratings remain — BTIG reaffirmed a buy with a $70 target, showing pockets of analyst optimism despite broad caution. Benzinga: BTIG Reaffirms Buy
  • Negative Sentiment: Broad downward revisions to price targets — Multiple firms (Citigroup, Morgan Stanley, JPMorgan, UBS, Wells Fargo, RBC, Piper Sandler, Baird, others) cut targets after the print, reflecting concerns about growth runway and execution; that pressure caps upside even with the beat. Blockonomi: Analyst Targets Slashed TickerReport: Citigroup Cut
  • Negative Sentiment: Valuation and growth trade‑offs highlighted — Analysts trimmed fair‑value estimates and flagged pricing/AI competition risks, underscoring why some investors remain cautious despite product progress. Yahoo Finance: Valuation and AI Risks

About Docusign

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

See Also

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.